Threonine

Threonine

SCHEMBL14924406

C[C@H](O)C(N)C(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Threonine SCHEMBL14946556 1.00 — —
Threonine SCHEMBL17292859 1.00 SLC7A5 (0.63) —
Threonine SCHEMBL117301 1.00 — —
Threonine SCHEMBL9461237 1.00 SLC7A5 (0.63) —
Threonine SCHEMBL1480 1.00 — —
Threonine SCHEMBL18050157 1.00 SLC7A5 (0.63) —
Threonine SCHEMBL6038228 1.00 SLC7A5 (0.63) —
Threonine SCHEMBL2702066 1.00 SLC7A5 (0.63) —
D-Allothreonine SCHEMBL222076 1.00 — —
Threonine SCHEMBL92730 1.00 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9862978-B2 Method for preparing (2RS)-amino-(3S)-hydroxy-butyric acid and its derivatives AMINOLOGICS CO. LTD. (KR) 2018-01-09 — — US claimed
US-20160017389-A1 METHOD FOR PREPARING (2RS)-AMINO-(3S)-HYDROXY-BUTYRIC ACID AND ITS DERIVATIVES AMINOLOGICS CO., LTD. (KR) 2016-01-21 — — US claimed
US-11576946-B2 Peptidyl inhibitors of calcineurin-NFAT interaction OHIO STATE INNOVATION FOUNDATION (US) 2023-02-14 — — US disclosed
US-20210169966-A1 PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION OHIO STATE INNOVATION FOUNDATION 2021-06-10 — — US disclosed
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed
EP-3305900-A1 ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES Nuevolution A/S (DK) 2018-04-11 — — EP disclosed
US-9862978-B2 Method for preparing (2RS)-amino-(3S)-hydroxy-butyric acid and its derivatives AMINOLOGICS CO. LTD. (KR) 2018-01-09 — — US disclosed
US-9862978-B2 Method for preparing (2RS)-amino-(3S)-hydroxy-butyric acid and its derivatives AMINOLOGICS CO. LTD. (KR) 2018-01-09 — — US disclosed
US-9862978-B2 Method for preparing (2RS)-amino-(3S)-hydroxy-butyric acid and its derivatives AMINOLOGICS CO. LTD. (KR) 2018-01-09 — — US disclosed
US-9862978-B2 Method for preparing (2RS)-amino-(3S)-hydroxy-butyric acid and its derivatives AMINOLOGICS CO. LTD. (KR) 2018-01-09 — — US disclosed
US-20160017389-A1 METHOD FOR PREPARING (2RS)-AMINO-(3S)-HYDROXY-BUTYRIC ACID AND ITS DERIVATIVES AMINOLOGICS CO., LTD. (KR) 2016-01-21 — — US disclosed
US-20160017389-A1 METHOD FOR PREPARING (2RS)-AMINO-(3S)-HYDROXY-BUTYRIC ACID AND ITS DERIVATIVES AMINOLOGICS CO., LTD. (KR) 2016-01-21 — — US disclosed
US-20160017389-A1 METHOD FOR PREPARING (2RS)-AMINO-(3S)-HYDROXY-BUTYRIC ACID AND ITS DERIVATIVES AMINOLOGICS CO., LTD. (KR) 2016-01-21 — — US disclosed
US-9227940-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2016-01-05 — — US disclosed
US-20150005342-A1 Hepatitis C Virus Inhibitors BRISTOL MYERS SQUIBB CO (US) 2015-01-01 — — US disclosed
WO-2014133291-A1 METHOD FOR PREPARING (2RS)-AMINO-(3S)-HYDROXY-BUTYRIC ACID OR DERIVATIVE THEREOF 주식회사 아미노로직스 (KR) 2014-09-04 — — WO disclosed
US-8629167-B2 Selective androgen receptor modulators RADIUS HEALTH, INC. (US) 2014-01-14 — — US disclosed
US-20130267713-A1 Hepatitis C Virus Inhibitors BRISTOL MYERS SQUIBB CO (US) 2013-10-10 — — US disclosed
US-20130116288-A1 Selective Androgen Receptor Modulators RADIUS HEALTH, INC. (US) 2013-05-09 — — US disclosed
Send feedback